Clinical Trial

Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis

Name: Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis — clinical trial record (NCT07093268)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated July 30, 2025 (before its estimated June 15, 2026 completion). Its status may not reflect the trial's current state.

Summary

The purpose of this study is to investigate the safety and tolerability of intrathecal riluzole in adults with amyotrophic lateral sclerosis.

Trial Details

NCT Number	NCT07093268
Lead Sponsor	Brain Trust Bio
Conditions	Amyotrophic Lateral Sclerosis, Motor Neuron Disease
Enrollment	10 participants
Start Date	2025-08-15
Primary Completion	2026-06-15 (estimated)
Study Completion	2027-01-15 (estimated)
Updated on ClinicalTrials.gov	2025-07-30